Key result
Certolizumab pegol therapy is linked to the development of induced heart failure.
Answers are grounded in this paper and cite their sources.
This report highlights a potential safety signal of heart failure induced by certolizumab pegol.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lazarewicz et al. (2017) studied this question. Certolizumab pegol therapy is associated with the development of induced heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: